Apexigen is a clinical-stage biopharmaceutical company focusing on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. The company’s pipeline of immuno-oncology therapeutic candidates is led by the APX005M program, which is currently in clinical development.
OnKure Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to improve the outcomes of patients afflicted with cancer. OnKure’s most advanced programs target Class-1 histone deacetylase (HDAC) enzymes as well as HDAC6.
12 Sigma Technologies was founded in April 2015. The company is one of the first companies to introduce artificial intelligent and deep learning into modern medical image diagnosis and medical data analysis.
Founded in 2003, Sanbo Brain Hospital is the leader of private hospitals in neurosurgery. The amount, difficulty and success rate of neurosurgery operation are the highest all cross China. Also it is the only private hospital as teaching affiliated hospital.
Founded in 2003, Mitralign is the only company in the world that has commercial devices for both mitral and tricuspid minimally invasive repairment. It is the minimally invasive valve device company with the largest patient number, longest follow-up, best outcomes, and fastest progress in clinical trials for tricuspid minimally-invasive devices.
Founded in 2007, MicuRx is a clinical-stage biopharmaceutical company discovering and developing innovative antibiotics for drug-resistant bacterial infections. The company has built a global leading pipeline which is closet to commercial stage.
Founded in September 2016, Uniceutiq focuses on the development of suspension drugs for pediatric use and is the only company in China that dedicated in the development of such drugs.
Founded in 2015, Changxi is focusing on research, development and commercialization of dry powder inhaler products, with the most experienced team and extensive pipeline.